Samuel D. Waksal
Use attributes for filter ! | |
Gender | Male |
---|---|
Age | 77 |
Date of birth | September 8,1947 |
Zodiac sign | Virgo |
Born | Paris |
France | |
Children | Aliza Waksal |
Elana Waksal | |
Siblings | Patti Waksal |
Harlan W. Waksal | |
Founded | ImClone Systems |
Kadmon Corporation | |
Board member of | Agenus |
The Rockefeller University | |
Job | Scientist |
Businessperson | |
Date of Reg. | |
Date of Upd. | |
ID | 426641 |
Samuel D. Waksal Life story
Samuel D. "Sam" Waksal is the founder and former CEO of the biopharmaceutical company ImClone Systems. He is also the founder of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010. At ImClone, Waksal led the company to develop the cancer drug Erbitux.